Colm Elliott (C Elliott)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Extracorporeal Membrane Oxygenation

Fluorescence Imaging

Top Venues

Multiple sclerosis (Houndmills, Basingstoke, England)

Brain : a journal of neurology

AJNR. American journal of neuroradiology

This page only lists publications with an associated author ORCID identifier.

Publications

Douglas L Arnold, Colm Elliott, Emily C Martin, Yann Hyvert, Davorka Tomic, Xavier Montalban
Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis: A Post Hoc Analysis of a Phase 2 Trial. Neurology 102 (5) (2024)
Francesca R Bagnato, Pascal Sati, Christopher C Hemond, Colm Elliott, Susan A Gauthier, Daniel M Harrison, Caterina Mainero, Jiwon Oh, David Pitt, Russell T Shinohara, Seth A Smith, Bruce D Trapp, Christina J Azevedo, Peter A Calabresi, Roland G Henry, Cornelia Laule, Daniel Ontaneda, William D Rooney, Nancy L Sicotte, Daniel S Reich, Martina Absinta
Imaging chronic active lesions in multiple sclerosis: a consensus statement. Brain : a journal of neurology (2024)
Douglas L Arnold, Colm Elliott, Emily C Martin, Yann Hyvert, Davorka Tomic, Xavier Montalban
Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis: A Post Hoc Analysis of a Phase 2 Trial. Neurology 102 (5) (2024)
Douglas L Arnold, Colm Elliott, Emily C Martin, Yann Hyvert, Davorka Tomic, Xavier Montalban
Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis: A Post Hoc Analysis of a Phase 2 Trial. Neurology 102 (5) (2024)
Francesca R Bagnato, Pascal Sati, Christopher C Hemond, Colm Elliott, Susan A Gauthier, Daniel M Harrison, Caterina Mainero, Jiwon Oh, David Pitt, Russell T Shinohara, Seth A Smith, Bruce Trapp, Christina J Azevedo, Peter A Calabresi, Roland G Henry, Cornelia Laule, Daniel Ontaneda, William D Rooney, Nancy L Sicotte, Daniel S Reich, Martina Absinta
Imaging chronic active lesions in multiple sclerosis: a consensus statement. Brain : a journal of neurology 147 (9) (2024)
Douglas L Arnold, Colm Elliott, Emily C Martin, Yann Hyvert, Davorka Tomic, Xavier Montalban
Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis: A Post Hoc Analysis of a Phase 2 Trial. Neurology 102 (5) (2024)
Douglas L Arnold, Colm Elliott, Emily C Martin, Yann Hyvert, Davorka Tomic, Xavier Montalban
Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis: A Post Hoc Analysis of a Phase 2 Trial. Neurology 102 (5) (2024)
Douglas L Arnold, Colm Elliott, Emily C Martin, Yann Hyvert, Davorka Tomic, Xavier Montalban
Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis: A Post Hoc Analysis of a Phase 2 Trial. Neurology 102 (5) (2024)
Shannon Kolind, Laura Gaetano, Haz-Edine Assemlal, Corrado Bernasconi, Ulrike Bonati, Colm Elliott, Niels Hagenbuch, Stefano Magon, Douglas L Arnold, Anthony Traboulsee
Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (6) (2023)
Shannon Kolind, Laura Gaetano, Haz-Edine Assemlal, Corrado Bernasconi, Ulrike Bonati, Colm Elliott, Niels Hagenbuch, Stefano Magon, Douglas L Arnold, Anthony Traboulsee
Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Shannon Kolind, Laura Gaetano, Haz-Edine Assemlal, Corrado Bernasconi, Ulrike Bonati, Colm Elliott, Niels Hagenbuch, Stefano Magon, Douglas L Arnold, Anthony Traboulsee
Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (6) (2023)
Shannon Kolind, Laura Gaetano, Haz-Edine Assemlal, Corrado Bernasconi, Ulrike Bonati, Colm Elliott, Niels Hagenbuch, Stefano Magon, Douglas L Arnold, Anthony Traboulsee
Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (6) (2023)
Xiaotong Jiang, Changyu Shen, Charlotte E Teunissen, Mark Hj Wessels, Henrik Zetterberg, Gavin Giovannoni, Carol M Singh, Bastien Caba, Colm Elliott, Elizabeth Fisher, Carl de Moor, Shibeshih Belachew, Arie R Gafson
Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Shannon Kolind, Laura Gaetano, Haz-Edine Assemlal, Corrado Bernasconi, Ulrike Bonati, Colm Elliott, Niels Hagenbuch, Stefano Magon, Douglas L Arnold, Anthony Traboulsee
Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (6) (2023)
Colm Elliott, David A Rudko, Douglas Lorne Arnold, Dumitru Fetco, Ahmed M Elkady, David Araujo, Bing Zhu, Arie Gafson, Zhe Tian, Shibeshih Belachew, Daniel P Bradley, Elizabeth Fisher
Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Shannon Kolind, Laura Gaetano, Haz-Edine Assemlal, Corrado Bernasconi, Ulrike Bonati, Colm Elliott, Niels Hagenbuch, Stefano Magon, Douglas L Arnold, Anthony Traboulsee
Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (6) (2023)
Colm Elliott, Parya Momayyezsiahkal, Douglas Lorne Arnold, Dawei Liu, Jun Ke, Li Zhu, Bing Zhu, Ilena C George, Daniel P Bradley, Elizabeth Fisher, Ellen Cahir-McFarland, Peter K Stys, Jeroen J G Geurts, Nathalie Franchimont, Arie Gafson, Shibeshih Belachew
Abnormalities in normal-appearing white matter from which multiple sclerosis lesions arise. Brain communications 3 (3) (2021)
Douglas Lorne Arnold, Shibeshih Belachew, Arie R Gafson, Laura Gaetano, Corrado Bernasconi, Colm Elliott
Slowly expanding lesions are a marker of progressive MS - No. Multiple sclerosis (Houndmills, Basingstoke, England) 27 (11) (2021)
Colm Elliott, Douglas Lorne Arnold, H Chen, Chunlei Ke, Li Zhu, I Chang, Ellen Cahir-McFarland, Elizabeth Fisher, Bing Zhu, S Gheuens, Matthew Scaramozza, V Beynon, Nathalie Franchimont, D P Bradley, Shibeshih Belachew
Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions. AJNR. American journal of neuroradiology 41 (9) (2020)
Josefina Maranzano, Mahsa Dadar, David A Rudko, Dante De Nigris, Colm Elliott, Joseph S Gati, Sarah A Morrow, Ravi S Menon, Lars Lau Raket, Douglas Lorne Arnold, Sridar Narayanan
Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI. AJNR. American journal of neuroradiology 40 (7) (2019)